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 Delivery of large therapeutic payloads to the central nervous system is challenging 
owing to the presence of the blood brain barrier (BBB) that inhibits uptake of virtually any 
macromolecule. Targeted nanostructures could overcome this issue, allowing delivery of 
otherwise impermeant payloads without suffering serum protein adsorption during circulation 
in the bloodstream. Here we present our results on the realization of a rationally designed 
targeted nanostructure tailored to in vivo use. 
Our strategy relies on the development of a stealth shell that inhibits serum protein adsorption 
without using immunogenic PEG derivatives. A zwitterionic peptide (EKEKEKE) with 
known stealth properties was conjugated with lipid tails and used to prepare liposome-like 
self-assembled structures that outperform PEG in terms of serum protein adhesion, being 
stable up to 8 hours in pure serum.1 
These structures were decorated with a targeting sequence that exploits transferrin receptor 
pathway. Transferrin (Tfn) is a promising target for delivery to the central nervous system 
(CNS) due to the overexpression of its receptor on the BBB. We designed and validated 
experimentally a new peptide aptamer (Tf2) able to recognize with good affinity transferrin 
without altering binding properties of the latter to its receptor.2 We shall show that the 
presence of Tf2 on the surface of a nanoparticle induces extensive modulation of the protein 
corona composition, with significant overrepresentation of Tfn. We will also show that Tf2-
decorated nanoparticles are efficiently assimilated by the cells in a transferrin-dependent 
fashion.2 
Finally, we shall present the applicability of our structure to enzyme replacement therapy for 
the treatment of Batten disease. Our nanostructures can be loaded with recombinant protein 
palmitoyl thiotransferase 1 fully retaining its activity. We shall discuss the effect of this 
administration on enzymatic activity recovery and on the phenotypic rescue in primary 
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